Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Strønen(Oslo University Hospital), Ton N. Schumacher(Leiden University Medical Center), Fridtjof Lund‐Johansen(Oslo University Hospital), Mireille Toebes(The Netherlands Cancer Institute), Marco Donia(University of Copenhagen), Johanna Olweus(Oslo University Hospital), Weiwen Yang(Oslo University Hospital), Maxi-Lu Böschen(Oslo University Hospital), Nienke van Rooij(The Netherlands Cancer Institute), Sander Kelderman(The Netherlands Cancer Institute), Marit M. van Buuren(The Netherlands Cancer Institute)
Cited by 448
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
|Journal of Clinical Oncology|2013|799
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
|Nature|2017|697
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
|Nature Medicine|2014|692
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
|Nature Medicine|2018|572